After comparing two patient cancer registries - one featuring transplant patients and the other the general population - researchers at the University of Cincinnati (UC) have found that transplant patients experience worse outcomes from cancer. These results were published in the May 15, 2009, edition...
Worse Cancer Outcomes For Transplant Patients, Analysis Shows
Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates. At the annual meeting of the American Society of Clinical Oncology (ASCO), Mayo investigators report that cancer in about...
Pfizer To Present New Clinical Data Highlighting Customized Treatment Approaches For Difficult-To-Treat Cancers
Pfizer will present new data highlighting the company’s commitment to a personalized approach to oncology clinical research, which includes the use of targeted agents in specific patient populations in several advanced and difficult-to-treat cancers. These data will be presented later this month...
Advances In Treatments For Patients With Myelodysplastic Syndromes Take Center Stage At 10th Annual International Symposium In Patras, Greece
The Myelodysplastic Syndromes (MDS) Foundation announced highlights from its successful 10th International Symposium on MDS, which was held in Patras, Greece. As the premier conference for MDS research, the meeting brought together more than 1100 of the leading scientists in the field from around the...
Minerva’s MUC1* Inhibitors Reverse Resistance To Chemotherapy
Minerva Biotechnologies, a leading cancer and stem cell development company, announced a major breakthrough in the treatment of cancers. In an article published this month in the Journal of Breast Cancer Research and Treatment, “MUC1* is a Determinant of Trastuzumab (Herceptin) Resistance in Breast...
Burzynski Research Institute Presents Positive Results From Phase II Trials Of ANP For Inoperable Brainstem Glioma At The Congress
The Burzynski Research Institute, Inc. (BRI) announced that it made three presentations of the results of phase II trials and mechanism of action data on it’s antineoplaston A10 and antineoplaston AS2-1 therapy (ANP). These findings were discussed at the 3rd Quadrennial Meeting of the World Federation...
City-Dwellers Have Higher Risk Of Late-Stage Cancer Than Rural Residents
People who live in urban areas are more likely to develop late-stage cancer than those who live in suburban and rural areas. That is the conclusion of a new study published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study’s results indicate...
American Association For Cancer Research Hosts Successful 100th Annual Meeting In Denver
The American Association for Cancer Research held its 100th Annual Meeting in Denver, Colo., in April and drew more than 15,000 people from all over the world to network and learn about the latest breakthroughs in scientific cancer research. The economic impact on Denver and the surrounding area was...
New Publication Sets Guidelines Across Cancer Therapies: Ensuring The Best In Patient Management
Now, for the first time, experts have compiled a comprehensive overview of the literature regarding the usefulness of PET imaging for the treatment of several cancers. Personalizing Cancer Therapy with FDG PET: From RECIST to PERCIST - a compilation of results of therapeutic regimens across a broad range...
2 Types Of Kidney Tumors Previously Thought To Be Different Diseases Are Variations Of The Same Disease
Van Andel Research Institute (VARI) investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney tumors previously thought to be different diseases are actually variations of the same disease. This finding will help doctors to more accurately diagnose...